Lv4
598 积分 2020-09-29 加入
The Role of IL-12 Family Cytokines in the Pathogenesis of Periodontal Disease: A Therapeutic Approach
14天前
已完结
Reframing IL-27: a central regulator of CD8+ T cell immunity
14天前
已完结
Reframing IL-27: a central regulator of CD8+ T cell immunity
14天前
已完结
Membrane-IL12 adjuvant mRNA vaccine polarizes pre-effector T cells for optimized tumor control
14天前
已完结
Antitumor power of oncolytic HSV engineered with IL-12 and IL-15
14天前
已关闭
An IL-12 renaissance: Engineering tumor-restricted IL-12 to improve solid tumor T cell therapies
14天前
已完结
Cytokine multimerization: when more is more and sometimes less
16天前
已完结
Strategies to therapeutically modulate cytokine action
16天前
已完结
Rewiring STAT signaling from the cell surface with Trikine immunotherapeutics
1个月前
已完结
Abstract 3118: IBI3026, a first-in-class anti-PD-1/IL-12 fusion protein, demonstrates the potential to be a new immuno-oncology therapy by releasing the break in immune response and strongly activating T and NK cells in the tumor microenvironment
2个月前
已完结
皖公网安备34019202002308
